Identifying factors affecting cancer progression and treatment in prostate, bladder, and kidney tumors
A Prospective Study of Clinical Factors Affecting Disease Progression and Treatment Results of Patients With Tumors of the Prostate, Bladder and Kidney.
Meir Medical Center · NCT02186925
This study looks at how different health factors, like medications and blood test results, affect the progression of prostate, bladder, and kidney cancers to help doctors create better treatment plans for their patients.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Meir Medical Center (other) |
| Locations | 1 site (Kvar Saba) |
| Trial ID | NCT02186925 on ClinicalTrials.gov |
What this trial studies
This observational study aims to identify clinical factors such as medications, background diseases, and blood test results that influence the progression of prostate, bladder, and kidney cancers. By analyzing these factors, the study seeks to provide insights that can help physicians tailor treatment plans for their patients. The research will involve patients being treated at Meir Medical Center who meet the eligibility criteria. The goal is to enhance understanding of how various clinical factors impact disease outcomes.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 18 years old diagnosed with prostate, bladder, or kidney cancer receiving treatment at Meir Medical Center.
Not a fit: Patients under the age of 18 will not benefit from this study as they are excluded from participation.
Why it matters
Potential benefit: If successful, this study could lead to more personalized and effective treatment strategies for patients with prostate, bladder, and kidney cancers.
How similar studies have performed: Other studies have shown success in identifying clinical factors that affect cancer treatment outcomes, indicating that this approach is supported by prior research.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients with prostate, bladder or kidney cancer that are being treated at the Meir Medical Center and are over 18 years of age. Exclusion Criteria: * Patients under the age of 18
Where this trial is running
Kvar Saba
- Meir Medical Center — Kvar Saba, Israel (RECRUITING)
Study contacts
- Principal investigator: Daneil Kejzman, MD — Meir Medical Center
- Study coordinator: Daniel Kejzman, MD
- Email: daniel.kejzman@clalit.org.il
- Phone: 00972-9747-1606
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Kidney Cancer, Prostate Cancer, Bladder Cancer